Biophytis Stock Z Score
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Biophytis |
Biophytis Company Z Score Analysis
Biophytis' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Biophytis has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Biophytis Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in z score category among its peers.
Biophytis Fundamentals
Return On Equity | -12.44 | |||
Return On Asset | -0.53 | |||
Current Valuation | 9.73 B | |||
Shares Outstanding | 286.5 K | |||
Shares Owned By Institutions | 0.04 % | |||
Number Of Shares Shorted | 368.95 K | |||
Price To Book | 2.26 X | |||
EBITDA | (15.09 M) | |||
Net Income | (17.03 M) | |||
Cash And Equivalents | 23.93 M | |||
Cash Per Share | 1.71 X | |||
Total Debt | 8.27 M | |||
Debt To Equity | 3.27 % | |||
Current Ratio | 1.37 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (13.33 M) | |||
Short Ratio | 0.41 X | |||
Earnings Per Share | (128.39) X | |||
Target Price | 6000.0 | |||
Number Of Employees | 22 | |||
Beta | 1.05 | |||
Market Capitalization | 2.61 M | |||
Total Asset | 11.94 M | |||
Retained Earnings | (19.38 M) | |||
Working Capital | (3.52 M) | |||
Net Asset | 11.94 M |
About Biophytis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biophytis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |